News

Shoulder Innovations (NYSE:SI) rose 8.55% on June 23, 2026, closing at $19.29 after a $1.52 per-share move. The session’s advance came as implant growth expectations pushed shares near a yearly high, based on the available company disclosures and trading context.

Monopar Therapeutics (NASDAQ:MNPR) rose 19.09% on June 23, 2026, closing at $81.77 after a $13.11 per-share move. The session’s advance came as institutional event raised visibility for the rare-disease pipeline, based on the available company disclosures and trading context.

SeaStar Medical (NASDAQ:ICU) rose 7.10% on June 23, 2026, closing at $3.47 after a $0.23 per-share move. The session’s advance came as technical rebound lifted the blood-purification developer, based on the available company disclosures and trading context.

Nkarta (NASDAQ:NKTX) rose 8.60% on June 23, 2026, closing at $3.03 after a $0.24 per-share move. The session’s advance came as new institutional coverage supported the cell-therapy developer, based on the available company disclosures and trading context.

REGENXBIO (NASDAQ:RGNX) rose 9.70% on June 23, 2026, closing at $9.95 after a $0.88 per-share move. The session’s advance came as FDA feedback supported an accelerated Navsunli filing path, based on the available company disclosures and trading context.

Lipocine (NASDAQ:LPCN) rose 10.48% on June 23, 2026, closing at $2.53 after a $0.24 per-share move. The session’s advance came as oral testosterone pipeline attracted speculative buying, based on the available company disclosures and trading context.

Monte Rosa Therapeutics (NASDAQ:GLUE) rose 10.93% on June 23, 2026, closing at $20.71 after a $2.04 per-share move. The session’s advance came as molecular glue partnership sustained pipeline enthusiasm, based on the available company disclosures and trading context.